Alphabet's Verily Life Sciences racks up $700m: Reuters

Verily Life Sciences LLC, Alphabet Inc’s life sciences division, has raised $700 million in funding, reported Reuters.

18 December 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles